Piper Sandler Maintains Overweight on Virtus Inv, Lowers Price Target to $170

Benzinga Newsdesk www.benzinga.com Negative 79.4%

Neg 79.4% Neu 0% Pos 0%

Piper Sandler analyst Crispin Love maintains Virtus Inv (NYSE:VRTS) with a Overweight and lowers the price target from $181 to $170.